DLRNA-BERTa: a transformer approach for predicting molecule-RNA binding affinities
Briefings in Bioinformatics · 01.09.2026 · 27 (5)
DOI: 10.1093/bib/bbag488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 11.09.2026. Verfasst von Pasquale Lobascio und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Tukholmankatu 8, FI-00290 Helsinki, Finland. Hauptthemen laut MEDLINE: RNA, Drug Discovery, Computational Biology, Software. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Research Council of Finland.
Abstract (Originalsprache)
Therapies targeting RNA are rapidly expanding, with 24 FDA-approved RNA therapeutics and over 130 currently in clinical trials, highlighting RNA’s growing role in drug discovery. In this context, transformer-based language models provide a scalable and cost-effective approach to accelerate RNA-targeted drug discovery by enabling the prediction of molecule–RNA binding affinities directly from sequence information. This study introduces DLRNA-BERTa, a RoBERTa-based framework that integrates RNA-BERTa and ChemBERTa-v2 to model molecule–RNA binding affinities. The framework includes six RNA class-specific models, aptamers, repeats, ribosomal RNAs, riboswitches, microRNAs, and viral RNAs, along with a general model for other RNA classes. DLRNA-BERTa outperformed existing approaches across different RNA classes on a randomly split validation dataset. On an independent and relatively diverse test set, the model achieved AUROC values of 0.57–0.59, demonstrating performance comparable to the other evaluated methods. Application of DLRNA-BERTa to a library of 3492 approved drugs identified 2859 compounds with predicted binding affinities (pKd ≥ 6) across 294 RNA targets, suggesting its potential utility for RNA-based drug repurposing and prioritization of candidate molecules for further investigation. To facilitate broader use and reproducibility, we provide a publicly accessible web application and API are available at https://huggingface.co/spaces/IlPakoZ/DLRNA-BERTa, enabling users to predict binding affinities between custom compounds and RNA sequences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Tukholmankatu 8, FI-00290 Helsinki, Finland.
- King Abdullah International Medical Research Center, Riyadh, Saudi Arabia, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, Ministry of the National Guard - Health Affairs, Ahmad Ibn Hanbal…
- Pakistan Institute of Engineering & Applied Sciences (PIEAS), Lehtrar Road, Nilore, 45650, Islamabad, Pakistan.
- BioICAWtech Oy, Helsinki, Finland.
ORCID-Profile: Ziaurrehman Tanoli
Förderung
- Research Council of Finland
Zitieren
APA
Lobascio, P., Saeed, K., Khan, A., & Tanoli, Z. (2026). DLRNA-BERTa: a transformer approach for predicting molecule-RNA binding affinities. Briefings in Bioinformatics, 27(5). https://doi.org/10.1093/bib/bbag488
Vancouver
Lobascio P, Saeed K, Khan A, Tanoli Z. DLRNA-BERTa: a transformer approach for predicting molecule-RNA binding affinities. Briefings in Bioinformatics. 2026;27(5). doi:10.1093/bib/bbag488
BibTeX
@article{Lobascio2026,
author = {Lobascio, Pasquale and Saeed, Khalid and Khan, Asifullah and Tanoli, Ziaurrehman},
title = {DLRNA-BERTa: a transformer approach for predicting molecule-RNA binding affinities},
journal = {Briefings in Bioinformatics},
year = {2026},
volume = {27},
number = {5},
doi = {10.1093/bib/bbag488}
}
EUVIMED